Correlation Between Silo Pharma and Algernon Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Silo Pharma and Algernon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silo Pharma and Algernon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Silo Pharma and Algernon Pharmaceuticals, you can compare the effects of market volatilities on Silo Pharma and Algernon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silo Pharma with a short position of Algernon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silo Pharma and Algernon Pharmaceuticals.
Diversification Opportunities for Silo Pharma and Algernon Pharmaceuticals
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Silo and Algernon is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Silo Pharma and Algernon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Algernon Pharmaceuticals and Silo Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silo Pharma are associated (or correlated) with Algernon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Algernon Pharmaceuticals has no effect on the direction of Silo Pharma i.e., Silo Pharma and Algernon Pharmaceuticals go up and down completely randomly.
Pair Corralation between Silo Pharma and Algernon Pharmaceuticals
Given the investment horizon of 90 days Silo Pharma is expected to generate 3.6 times less return on investment than Algernon Pharmaceuticals. But when comparing it to its historical volatility, Silo Pharma is 1.19 times less risky than Algernon Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Algernon Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 41.00 in Algernon Pharmaceuticals on September 2, 2024 and sell it today you would lose (35.51) from holding Algernon Pharmaceuticals or give up 86.61% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 99.6% |
Values | Daily Returns |
Silo Pharma vs. Algernon Pharmaceuticals
Performance |
Timeline |
Silo Pharma |
Algernon Pharmaceuticals |
Silo Pharma and Algernon Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Silo Pharma and Algernon Pharmaceuticals
The main advantage of trading using opposite Silo Pharma and Algernon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silo Pharma position performs unexpectedly, Algernon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Algernon Pharmaceuticals will offset losses from the drop in Algernon Pharmaceuticals' long position.Silo Pharma vs. Rezolute | Silo Pharma vs. Lumos Pharma | Silo Pharma vs. Anebulo Pharmaceuticals | Silo Pharma vs. Sino Biopharmaceutical Limited |
Algernon Pharmaceuticals vs. Rigel Pharmaceuticals | Algernon Pharmaceuticals vs. Geron | Algernon Pharmaceuticals vs. Verastem | Algernon Pharmaceuticals vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Commodity Directory Find actively traded commodities issued by global exchanges |